EUVIMEDEUVIMED entdecken
Vergleichsstudie

Direct Oral Anticoagulants Are Associated With Less Bleeding Risk Than Warfarin in Patients Undergoing Liver Resections

Abdullah Sohail, Mary T Powers, Tricia Suarez, Kathryn Wittrock, Faisal S Jehan, Yong K Kwon, Hassan Aziz

Journal of Surgical Research · 2026-05 · 321 · 383-388

DOI: 10.1016/j.jss.2026.02.032 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Surgical Research, 2026-05. Verfasst von Abdullah Sohail und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, University of Iowa Hospitals and Clinics, Iowa City, Iowa. Hauptthemen laut MEDLINE: Warfarin, Anticoagulants, Postoperative Hemorrhage, Hepatectomy. Die Arbeit nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION The safety profile of direct oral anticoagulants (DOACs) compared to warfarin in patients undergoing liver resections remains an area of active research. METHODS We performed a retrospective analysis of the TriNetX database. Patients were categorized into two groups based on the anticoagulant they were on before surgery: DOACs or warfarin. The primary outcome measure was postoperative hemorrhage. RESULTS After propensity score matching, there were 1301 patients in each group. Patients taking preoperative DOACs were less likely to have intraoperative hemorrhage (0.76% versus 2.1%; P < 0.01). There was no difference in the need for postoperative angioembolization between the two groups (0.76% versus 0.75%; P = 1) or 30-d mortality (0.92% versus 1.7%; P = 0.06). A higher incidence of postoperative deep vein thrombosis/pulmonary embolism was observed in the warfarin group (16.4% versus 20.5%, P < 0.01). CONCLUSIONS This study suggests that DOACs demonstrate an improved safety profile compared to warfarin in patients undergoing liver resections. While further investigation is needed to uncover the underlying mechanism of these findings, the current trend in prescribing DOACs over warfarin is supported by the increase in positive outcomes, as seen in these results.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

WarfarinAnticoagulantsPostoperative HemorrhageHepatectomyFactor Xa InhibitorsHumansFemaleRetrospective StudiesMaleAgedMiddle AgedAdministration, OralAged, 80 and overVenous ThrombosisRisk FactorsIncidencePulmonary Embolism

Stichwörter der Autor:innen

BleedingDirect oral anticoagulantsLiver surgeryWarfarin

Substanzen

WarfarinAnticoagulantsFactor Xa Inhibitors

Autor:innen und Institutionen

  • Department of Surgery, University of Iowa Hospitals and Clinics, Iowa City, Iowa.
  • Department of Surgery, University of Arizona, Tucson, Arizona.
  • Department of Surgery, UT Southwestern Medical Center, Dallas, Texas.
  • Department of Surgery, University of Iowa Hospitals and Clinics, Iowa City, Iowa. Electronic address: Hassan-aziz@uiowa.edu.

Zitieren

APA

Sohail, A., Powers, M. T., Suarez, T., Wittrock, K., Jehan, F. S., Kwon, Y. K., & Aziz, H. (2026). Direct Oral Anticoagulants Are Associated With Less Bleeding Risk Than Warfarin in Patients Undergoing Liver Resections. Journal of Surgical Research, 321, 383-388. https://doi.org/10.1016/j.jss.2026.02.032

Vancouver

Sohail A, Powers MT, Suarez T, Wittrock K, Jehan FS, Kwon YK, et al. Direct Oral Anticoagulants Are Associated With Less Bleeding Risk Than Warfarin in Patients Undergoing Liver Resections. Journal of Surgical Research. 2026;321:383-388. doi:10.1016/j.jss.2026.02.032

BibTeX
@article{Sohail2026,
  author = {Sohail, Abdullah and Powers, Mary T and Suarez, Tricia and Wittrock, Kathryn and Jehan, Faisal S and Kwon, Yong K and Aziz, Hassan},
  title = {Direct Oral Anticoagulants Are Associated With Less Bleeding Risk Than Warfarin in Patients Undergoing Liver Resections},
  journal = {Journal of Surgical Research},
  year = {2026},
  volume = {321},
  pages = {383--388},
  doi = {10.1016/j.jss.2026.02.032}
}
Kostenlos starten →